作者
- Adams, K.F. (33)
- Albert, N.M. (15)
- Califf, R.M. (11)
- Fonarow, G.C. (21)
- Gattis, W.A. (27)
- Gheorghiade, M. (109)
- O'Connor, C.M. (51)
- Stough, W.G. (11)
- Yancy, C.W. (14)
- Young, J.B. (11)
|
總筆數:109
| 篇名 | 作者 | 刊名 | 出版年 | 查看 |
|---|
| Decline in the rate of hospital mortality from acute myocardial infarction:Impact of changing management strategies |
Gheorghiade, M.;Ruzumna, P.;Borzak, S.;Havstad, S.;Ali, A.;Goldstein, S.; |
American Heart Journal |
1996-02-01 |
查看 |
| Is there a role for thiamine supplementation in the management of heartfailure? |
Leslie, D.;Gheorghiade, M.; |
American Heart Journal |
1996-06-01 |
查看 |
| Digitalis Investigation Group (DIG) trial: A stimulus for furtherresearch |
Gheorghiade, M.;Pitt, B.; |
American Heart Journal |
1997-07-01 |
查看 |
| A randomized controlled trial of epoprostenol therapy for severecongestive heart failure: The Flolan International Randomized SurvivalTrial (FIRST) |
Califf, R.M.;Adams, K.F.;McKenna, W.J.;Gheorghiade, M.;Uretsky, B.F.;McNulty, S.E.;Darius, H.;Schulman, K.;Zannad, F.;Handberg-Thurmond, E.;Harrell, F.E.;Wheeler, W.;Soler-Soler, J.;Swedberg, K.; |
American Heart Journal |
1997-07-01 |
查看 |
| Digitalis Investigation Group (DIG) trial: A stimulus for furtherresearch |
Gheorghiade, M.;Pitt, B.; |
American Heart Journal |
1997-07-01 |
查看 |
| A randomized controlled trial of epoprostenol therapy for severecongestive heart failure: The Flolan International Randomized SurvivalTrial (FIRST) |
Califf, R.M.;Adams, K.F.;McKenna, W.J.;Gheorghiade, M.;Uretsky, B.F.;McNulty, S.E.;Darius, H.;Schulman, K.;Zannad, F.;Handberg-Thurmond, E.;Harrell, F.E.;Wheeler, W.;Soler-Soler, J.;Swedberg, K.; |
American Heart Journal |
1997-07-01 |
查看 |
| Systolic function, readmission rates, and survival among consecutivelyhospitalized patients with congestive heart failure |
McDermott, M.M.;Feinglass, J.;Lee, P.I.;Mehta, S.;Schmitt, B.;Lefevre, F.;Gheorghiade, M.; |
American Heart Journal |
1997-10-01 |
查看 |
| Systolic function, readmission rates, and survival among consecutivelyhospitalized patients with congestive heart failure |
McDermott, M.M.;Feinglass, J.;Lee, P.I.;Mehta, S.;Schmitt, B.;Lefevre, F.;Gheorghiade, M.; |
American Heart Journal |
1997-10-01 |
查看 |
| Heart failure between 1986 and 1994: Temporal trends indrug-prescribing practices, hospital readmissions, and survival at anacademic medical center |
McDermott, M.M.;Feinglass, J.;Lee, P.;Mehta, S.;Schmitt, B.;Lefevre, F.;Puppala, J.;Gheorghiade, M.; |
American Heart Journal |
1997-11-01 |
查看 |
| Heart failure between 1986 and 1994: Temporal trends indrug-prescribing practices, hospital readmissions, and survival at anacademic medical center |
McGrae, M.;Feinglass, J.;Lee, P.;Mehta, S.;Schmitt, B.;Lefevre, F.;Puppala, J.;Gheorghiade, M.; |
American Heart Journal |
1997-11-01 |
查看 |
| Heart failure between 1986 and 1994: Temporal trends indrug-prescribing practices, hospital readmissions, and survival at anacademic medical center |
McGrae, M.;Feinglass, J.;Lee, P.;Mehta, S.;Schmitt, B.;Lefevre, F.;Puppala, J.;Gheorghiade, M.; |
American Heart Journal |
1997-11-01 |
查看 |
| Effects of propranolol in patients entered in the Beta-Blocker HeartAttack Trial with their first myocardial infarction and persistentelectrocardiographic ST-segment depression |
Shivkumar, K.;Schultz, L.;Goldstein, S.;Gheorghiade, M.; |
American Heart Journal |
1998-02-01 |
查看 |
| Clinical predictors of worsening heart failure during withdrawal fromdigoxin therapy |
Adams, K.F.;Gheorghiade, M.;Uretsky, B.F.;Young, J.B.;Patterson, J.;Tomasko, L.;Packer, M.; |
American Heart Journal |
1998-03-01 |
查看 |
| Clinical predictors of worsening heart failure during withdrawal fromdigoxin therapy |
Adams, K.F.;Gheorghiade, M.;Uretsky, B.F.;Young, J.B.;Patterson, J.;Tomasko, L.;Packer, M.; |
American Heart Journal |
1998-03-01 |
查看 |
| Correction |
McDermott, M.M.;Gheorghiade, M.; |
American Heart Journal |
1998-05-01 |
查看 |
| Correction |
McDermott, M.M.;Gheorghiade, M.; |
American Heart Journal |
1998-05-01 |
查看 |
| Introduction |
Califf, R.M.;Gheorghiade, M.; |
American Heart Journal |
1998-06-01 |
查看 |
| Heart failure associated with preserved systolic function: A common andcostly clinical entity |
Dauterman, K.W.;Massie, B.M.;Gheorghiade, M.; |
American Heart Journal |
1998-06-01 |
查看 |
| The pathophysiology of advanced heart failure |
Baig, M.;Mahon, N.;McKenna, W.J.;Caforio, A.L.P.;Bonow, R.O.;Francis, G.S.;Gheorghiade, M.; |
American Heart Journal |
1998-06-01 |
查看 |
| Current medical therapy for advanced heart failure |
Gheorghiade, M.;Cody, R.J.;Francis, G.S.;McKenna, W.J.;Young, J.B.;Bonow, R.O.; |
American Heart Journal |
1998-06-01 |
查看 |
| Reply |
Gheorghiade, M.;Pitt, B.; |
American Heart Journal |
1998-11-01 |
查看 |
| Reply |
Gheorghiade, M.;Pitt, B.; |
American Heart Journal |
1998-11-01 |
查看 |
| Lower thrombolytic use for African Americans with myocardial infarction: Aninfluence of clinical presentation? |
Borzak, S.;Joseph, C.;Havstad, S.;Tilley, B.;Smith, S.T.;Housholder, S.D.;Gheorghiade, M.; |
American Heart Journal |
1999-02-01 |
查看 |
| Lower thrombolytic use for African Americans with myocardialinfarction: An influence of clinical presentation? |
Borzak, S.;Joseph, C.;Havstad, S.;Tilley, B.;Smith, S.T.;Housholder, S.D.;Gheorghiade, M.; |
American Heart Journal |
1999-02-01 |
查看 |
| Growth hormone therapy in patients with congestive heart failure: Needfor further research |
Johnson, M.R.;Gheorghiade, M.; |
American Heart Journal |
1999-06-01 |
查看 |
| Growth hormone therapy in patients with congestive heart failure: Needfor further research |
Johnson, M.R.;Gheorghiade, M.; |
American Heart Journal |
1999-06-01 |
查看 |
| Continuous intravenous dobutamine is associated with an increased riskof death in patients with advanced heart failure: Insights from the FlolanInternational Randomized Survival Trial (FIRST) |
For the FIRST Investigators;O'Connor, C.M.;Gattis, W.A.;Uretsky, B.F.;Adams, K.F.;McNulty, S.E.;Grossman, S.H.;McKenna, W.J.;Zannad, F.;Swedberg, K.;Gheorghiade, M.;Califf, R.M.; |
American Heart Journal |
1999-07-01 |
查看 |
| Continuous intravenous dobutamine is associated with an increased riskof death in patients with advanced heart failure: Insights from the FlolanInternational Randomized Survival Trial (FIRST) |
For the FIRST Investigators;O'Connor, C.M.;Gattis, W.A.;Uretsky, B.F.;Adams, K.F.;McNulty, S.E.;Grossman, S.H.;McKenna, W.J.;Zannad, F.;Swedberg, K.;Gheorghiade, M.;Califf, R.M.; |
American Heart Journal |
1999-07-01 |
查看 |
| A randomized trial of ecadotril versus placebo in patients with mild tomoderate heart failure: The U.S. Ecadotril Pilot Safety Study |
For the U.S. Ecadotril Investigators;O'Connor, C.M.;Gattis, W.A.;Gheorghiade, M.;Granger, C.B.;Gilbert, J.;McKenney, J.M.;Messineo, F.C.;Burnett, J.C.;Katz, S.D.;Elkayam, U.;Kasper, E.K.;Goldstein, S.;Cody, R.J.;Massie, B.M.; |
American Heart Journal |
1999-12-01 |
查看 |
| Metoprolol CR/XL in patients with heart failure: A pilot studyexamining the tolerability, safety, and effect on left ventricular ejectionfraction |
Goldstein, S.;Kennedy, H.L.;Hall, C.;Anderson, J.L.;Gheorghiade, M.;Gottlieb, S.;Jessup, M.;Karlsberg, R.P.;Friday, G.;Haskell, L.; |
American Heart Journal |
1999-12-01 |
查看 |
| A randomized trial of ecadotril versus placebo in patients with mild tomoderate heart failure: The U.S. Ecadotril Pilot Safety Study |
For the U.S. Ecadotril Investigators;O'Connor, C.M.;Gattis, W.A.;Gheorghiade, M.;Granger, C.B.;Gilbert, J.;McKenney, J.M.;Messineo, F.C.;Burnett, J.C.;Katz, S.D.;Elkayam, U.;Kasper, E.K.;Goldstein, S.;Cody, R.J.;Massie, B.M.; |
American Heart Journal |
1999-12-01 |
查看 |
| Metoprolol CR/XL in patients with heart failure: A pilot studyexamining the tolerability, safety, and effect on left ventricular ejectionfraction |
Goldstein, S.;Kennedy, H.L.;Hall, C.;Anderson, J.L.;Gheorghiade, M.;Gottlieb, S.;Jessup, M.;Karlsberg, R.P.;Friday, G.;Haskell, L.; |
American Heart Journal |
1999-12-01 |
查看 |
| Rationale and design of the OPTIME CHF trial: Outcomes of a prospectivetrial of intravenous milrinone for exacerbations of chronic heart failure |
Cuffe, M.S.;Califf, R.M.;Adams, K.F.;Bourge, R.C.;Colucci, W.;Massie, B.;O'Connor, C.M.;Pina, I.;Quigg, R.;Silver, M.;Robinson, L.A.;Leimberger, J.D.;Gheorghiade, M.; |
American Heart Journal |
2000-01-01 |
查看 |
| Rationale and design of the OPTIME CHF trial: Outcomes of a ProspectiveTrial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure |
Cuffe, M.S.;Califf, R.M.;Adams, K.F.;Bourge, R.C.;Colucci, W.;Massie, B.;O'Connor, C.M.;Pina, I.;Quigg, R.;Silver, M.;Robinson, L.A.;Leimberger, J.D.;Gheorghiade, M.; |
American Heart Journal |
2000-01-01 |
查看 |
| Rationale and design of the OPTIME CHF trial: Outcomes of a ProspectiveTrial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure |
Cuffe, M.S.;Califf, R.M.;Adams, K.F.;Bourge, R.C.;Colucci, W.;Massie, B.;O'Connor, C.M.;Pina, I.;Quigg, R.;Silver, M.;Robinson, L.A.;Leimberger, J.D.;Gheorghiade, M.; |
American Heart Journal |
2000-01-01 |
查看 |
| Hemodynamics as surrogate end points for survival in advanced heartfailure: An analysis from FIRST |
Shah, M.R.;Stinnett, S.S.;McNulty, S.E.;Gheorghiade, M.;Zannad, F.;Uretsky, B.;Adams, K.F.;Califf, R.M.;O'Connor, C.M.; |
American Heart Journal |
2001-06-01 |
查看 |
| Hemodynamics as surrogate end points for survival in advanced heartfailure: An analysis from FIRST |
Shah, M.R.;Stinnett, S.S.;McNulty, S.E.;Gheorghiade, M.;Zannad, F.;Uretsky, B.;Adams, K.F.;Califf, R.M.;O'Connor, C.M.; |
American Heart Journal |
2001-06-01 |
查看 |
| Hemodynamics as surrogate end points for survival in advanced heartfailure: An analysis from FIRST |
Shah, M.R.;Stinnett, S.S.;McNulty, S.E.;Gheorghiade, M.;Zannad, F.;Uretsky, B.;Adams, K.F.;Califf, R.M.;O'Connor, C.M.; |
American Heart Journal |
2001-06-01 |
查看 |
| Relative lymphocyte count: A prognostic indicator of mortality in elderlypatients with congestive heart failure |
Acanfora, D.;Gheorghiade, M.;Trojano, L.;Furgi, G.;Pasini, E.;Picone, C.;Papa, A.;Iannuzzi, G.L.;Bonow, R.O.;Rengo, F.;the CHF Italian Study Investigators; |
American Heart Journal |
2001-07-01 |
查看 |
| Relative lymphocyte count: A prognostic indicator of mortality inelderly patients with congestive heart failure |
Acanfora, D.;Gheorghiade, M.;Trojano, L.;Furgi, G.;Pasini, E.;Picone, C.;Papa, A.;Iannuzzi, G.L.;Bonow, R.O.;Rengo, F.;the CHF Italian Study Investigators; |
American Heart Journal |
2001-07-01 |
查看 |
| Tezosentan in patients with acute heart failure and acute coronarysyndromes: Design of the Randomized Intravenous Tezosentan Study (RITZ-4) |
O'Connor, C.M.;Gattis, W.A.;Adams, K.F.;Shah, M.R.;Kobrin, I.;Frey, A.;Gheorghiade, M.;RITZ-4 Investigators; |
American Heart Journal |
2002-10-01 |
查看 |
| Tezosentan in patients with acute heart failure and acute coronarysyndromes: Design of the Randomized Intravenous Tezosentan Study (RITZ-4) |
O'Connor, C.M.;Gattis, W.A.;Adams, K.F.;Shah, M.R.;Kobrin, I.;Frey, A.;Gheorghiade, M.;RITZ-4 Investigators; |
American Heart Journal |
2002-10-01 |
查看 |
| Introduction |
Gheorghiade, M.;Gattis, W.A.;O'Connor, C.M.;Adams, K.F.; |
American Heart Journal |
2003-02-01 |
查看 |
| Current medical treatment for the exacerbation of chronic heart failureresulting in hospitalization |
Jain, P.;Massie, B.M.;Gattis, W.A.;Klein, L.;Gheorghiade, M.; |
American Heart Journal |
2003-02-01 |
查看 |
| The problem of decompensated heart failure: Nomenclature, classification,and risk stratification |
Felker, G.M.;Adams, K.F.;Konstam, M.A.;O'Connor, C.M.;Gheorghiade, M.; |
American Heart Journal |
2003-02-01 |
查看 |
| B-Type natriuretic peptide: From bench to bedside |
Adams, K.F.;Mathur, V.S.;Gheorghiade, M.; |
American Heart Journal |
2003-02-01 |
查看 |
| Design considerations and proposed template for clinical trials inhospitalized patients with decompensated chronic heart failure |
O'Connor, C.M.;Gattis, W.A.;Teerlink, J.R.;Adams, K.F.;Gheorghiade, M.; |
American Heart Journal |
2003-02-01 |
查看 |
| Rationale and study design for a multicenter, randomized, double-blind,placebo-controlled study of the effects of tolvaptan on the acute andchronic outcomes of patients hospitalized with worsening congestive heartfailure |
Gheorghiade, M.;Gattis, W.A.;Barbagelata, A.;Adams, K.F.;Elkayam, U.;Orlandi, C.;O'Connor, C.M.;Acute and Chronic Therapeutic Impact of a Vasopressin Antagonist in;Congestive Heart Failure (ACTIV in CHF) Investigators; |
American Heart Journal |
2003-02-01 |
查看 |
| Rationale and design of the pilot randomized study of nesiritide versusdobutamine in heart failure (PRESERVD-HF) |
Gheorghiade, M.;Gattis, W.A.;Adams, K.F.;Jaffe, A.S.;O'Connor, C.M.;Duke University Cooperative Cardiovascular Studies (DUCCS) Investigators; |
American Heart Journal |
2003-02-01 |
查看 |
| Tezosentan in patients with acute heart failure and acute coronarysyndromes: Design of the fourth Randomized Intravenous Tezosentan Study(RITZ-4) |
O'Connor, C.M.;Gattis, W.A.;Adams, K.F.;Shah, M.R.;Frey, A.;Gheorghiade, M.;RITZ-4 Investigators; |
American Heart Journal |
2003-02-01 |
查看 |
| Rationale and design of the Initiation Management Predischarge: Process forAssessment of Carvedilol Therapy for Heart Failure (IMPACT-HF) study |
Gheorghiade, M.;Gattis, W.A.;Lukas, M.A.;O'Connor, C.M.;IMPACT-HF Investigators; |
American Heart Journal |
2003-02-01 |
查看 |
| Concomitant use of a positive inotropic agent to create a bridge to thesuccessful initiation of @b-blocker therapy in patients with heart failure:A proposal for a trial |
Zampino, M.;O'Connor, C.M.;Gattis, W.A.;Adams, K.F.;Gheorghiade, M.; |
American Heart Journal |
2003-02-01 |
查看 |
|
|
|
